Surmounting Chemoresistance by Targeting the Y-Box Binding Protein-1

Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1

(2011) Valentina Evdokimova et al.   CELL CYCLE

p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance

(2010) Ji Yeon Yang et al.   BMC CANCER

Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells

(2010) J.A. Muñoz-Gámez et al.   CANCER LETTERS

Y-Box Binding Protein-1 Induces the Expression ofCD44andCD49fLeading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

(2010) Karen To et al.   CANCER RESEARCH

Y-box binding protein-1 is a novel molecular target for tumor vessels

(2010) Mayu Takahashi et al.   CANCER SCIENCE

P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance

(2010) Masaki Shiota et al.   CANCER SCIENCE

Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells

(2010) Yuji Basaki et al.   EUROPEAN JOURNAL OF CANCER

Designing highly active siRNAs for therapeutic applications

(2010) S. Patrick Walton et al.   FEBS Journal

Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells

(2010) Karsten Jürchott et al.   PLoS Genetics

Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade

(2009) J. Zheng et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition

(2009) Valentina Evdokimova et al.   CANCER CELL

Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth

(2009) M. Shiota et al.   CANCER RESEARCH

Y-Box–Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy

(2009) Oleg Gluz et al.   JOURNAL OF CLINICAL ONCOLOGY

Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing

(2009) S B Cohen et al.   ONCOGENE

Twist Promotes Tumor Cell Growth through YB-1 Expression

(2008) M. Shiota et al.   CANCER RESEARCH

The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells

(2008) David Guay et al.   CANCER SCIENCE

Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression

(2008) Samuel Godar et al.   CELL

Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells

(2008) Lilly Y. W. Bourguignon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

RBBP6 Interacts with Multifunctional Protein YB-1 through Its RING Finger Domain, Leading to Ubiquitination and Proteosomal Degradation of YB-1

(2008) Moredreck Chibi et al.   JOURNAL OF MOLECULAR BIOLOGY

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

(2008) X. Li et al.   JNCI-Journal of the National Cancer Institute

Y-Box-binding protein-1 is a promising predictive marker of radioresistance and chemoradioresistance in nasopharyngeal cancer

(2008) Wei-Lin Tay et al.   MODERN PATHOLOGY

Regulatory Role of Human AP-Endonuclease (APE1/Ref-1) in YB-1-Mediated Activation of the Multidrug Resistance Gene MDR1

(2008) R. Chattopadhyay et al.   MOLECULAR AND CELLULAR BIOLOGY